- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03559036
Pediatric Locomotor Training Bladder Study
March 19, 2024 updated by: Charles Hubscher, University of Louisville
Impact of Activity-Dependent Plasticity on Bladder Function After Pediatric Spinal Cord Injury
Bladder dysfunction is one of the most important factors influencing duration and quality of life in children with spinal cord injury.
Effective bladder control comprises a major aspect of a child's life with SCI and is especially challenging due to the rapid changes in a child's physical and cognitive development.
Urological consequences secondary to a neurogenic bladder are responsible for many clinical complications post-spinal cord injury, including repeated urinary tract infections, autonomic dysreflexia, lifelong urologic care, and many hospitalizations.
Alternative approaches to bladder management that focus on recovery of function and age-appropriate independence are needed.
Prior research findings in our lab in adult participants indicate a benefit of locomotor training on bladder function.
The purpose of this study is to determine with quantitative unbiased urodynamic outcome measures if locomotor training, provided to children with spinal cord injury, impacts the developing urinary system.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Detailed Description
Our overall hypothesis is that spinal cord injury-induced bladder dysfunction, facilitated by the loss of supra-spinal connections and subsequent alterations of the lumbosacral circuitry, can be ameliorated through activity-based therapy that regulates the state of detrusor-sphincter dyssynergia and normalizes release of neurotrophic factors known to contribute to bladder hyper-reflexia.
The primary study aim is to determine the effects of weight-bearing task-specific training for locomotion (stepping on a treadmill) after incomplete and complete spinal cord injury in children on bladder storage, voiding, biomarkers, and quality of life (parent-reported during baseline and exit interview).
A secondary aim is to develop a scale for classifying bladder recovery after spinal cord injury based either on the pattern of storage and voiding prior to injury (if the child had bladder control prior to injury) or on established patterns of micturition development (if the child was injured prior to experiencing bladder control).
Study Type
Observational
Enrollment (Estimated)
6
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Kentucky
-
Louisville, Kentucky, United States, 40202
- University of Louisville
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
2 years to 18 years (Child, Adult)
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
Children, 2 to 18 years old, who sustained an upper motor neuron spinal cord injury and are medically approved for enrollment in an outpatient, standardized locomotor training program at the University of Louisville (either clinic or research-based) are eligible for participation.
Each participant will serve as his/her own control reducing the variability among individuals related to the injury itself, time since injury, medications taken, therapies received, differences in degree of bladder dysfunction, capacity to independently void prior to injury, and many other factors that cannot be controlled in the human experience.
Description
Inclusion Criteria:
- Supra-sacral, non-progressive spinal cord injury
- Bladder dysfunction post-injury
Exclusion Criteria:
- Use of anti-spasticity medications or unwillingness to wean off of medications
- Botox (onabotulinumtoxinA) in the bladder within 9 months of the study
- Bladder dysfunction or urinary tract impairment prior to injury
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Locomotor Training
Assessments for bladder function will be conducted pre-training and following 80 sessions of locomotor training.
Locomotor training consists of body-weight supported stepping on a treadmill for one hour.
|
Body-weight supported stepping on a treadmill.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Bladder Storage
Time Frame: 2 years
|
Bladder Capacity
|
2 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Bladder Emptying
Time Frame: 2 years
|
Voiding Efficiency
|
2 years
|
|
Bladder Pressure
Time Frame: 2 years
|
Leak Point and Maximum Pressure
|
2 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Charles Hubscher, PhD, University of Louisville
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 26, 2018
Primary Completion (Estimated)
December 30, 2025
Study Completion (Estimated)
June 30, 2026
Study Registration Dates
First Submitted
June 5, 2018
First Submitted That Met QC Criteria
June 5, 2018
First Posted (Actual)
June 15, 2018
Study Record Updates
Last Update Posted (Actual)
March 20, 2024
Last Update Submitted That Met QC Criteria
March 19, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Central Nervous System Diseases
- Nervous System Diseases
- Urologic Diseases
- Urinary Bladder Diseases
- Neurologic Manifestations
- Wounds and Injuries
- Trauma, Nervous System
- Spinal Cord Diseases
- Female Urogenital Diseases
- Female Urogenital Diseases and Pregnancy Complications
- Urogenital Diseases
- Male Urogenital Diseases
- Spinal Cord Injuries
- Urinary Bladder, Neurogenic
Other Study ID Numbers
- 17.1007
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.